A kind of chitosan/mxene antibacterial composite sponge for hemostasis and preparation method thereof
A technology of composite sponge and chitosan, applied in application, pharmaceutical formulation, surgical adhesive and other directions, can solve the problems of poor flexibility of hemostatic sponge, increased process complexity, insignificant hemostatic effect, etc., and is conducive to large-scale industrial production. , Improve flexibility, expand the effect of application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Preparation of hemostasis chitosan / MXENE antibacterial composite sponge, the specific steps are as follows:
[0033] (1) Under stirring conditions, chitosan having a molecular weight of 100,000 was added to a acetic acid solution having a volume percent concentration of 0.4% to obtain a chitosanic acid solution having a chitosan concentration of 5 g / L.
[0034] (2) Under stirring, N- (2-hydroxyethyl) acrylamide (N- (2-hydroxyethyl) acrylamide (N- (2-hydroxyethyl) acrylamide is added to the chitosan acetate solution to the chitosanic acid solution. Uniform, given a mixed solution;
[0035] (3) Under stirring conditions, add Ti to a mixed solution. 3 C 2 T x , Mix evenly, get 0.5 g / l ti 3 C 2 T x Chitosan / N- (2-hydroxyethyl) acrylamide / Ti 3 C 2 T x The mixed solution; the mixed solution was freeze dried to give the hemostasis chitosan / MXENE antibacterial composite sponge.
[0036] Example 1 The chitosan / MXENE antibacterial composite sponge showed a complex longi...
Embodiment 2
[0040] Preparation of hemostasis chitosan / MXENE antibacterial composite sponge, the specific steps are as follows:
[0041] (1) Under stirring conditions, the molecular weight is added to a acetic acid solution having a molecular weight concentration of 0.5% by 0.5% by weight, to obtain a chitosanic acetate acid solution having a chitosan concentration of 5 g / L;
[0042] (2) Under stirring conditions, N- (2-hydroxyethyl) acrylamide (1: 2 of the chitosan) was mixed in the chitosanic acetate solution to obtain a mixed solution;
[0043] (3) Under stirring conditions, add Ti to a mixed solution. 3 C 2 T x , Mix evenly, get 5g / lti 3 C 2 T x Chitosan / N- (2-hydroxyethyl) acrylamide / Ti 3 C 2 T x The mixed solution; the mixed solution was freeze dried to give the hemostasis chitosan / MXENE antibacterial composite sponge.
[0044] Example 2 Micro-morphological data for chitosan / MXENE antibacterial composite sponge figure 1 Indicated by figure 1 It can be seen that the composite...
Embodiment 3
[0048] Preparation of hemostasis chitosan / MXENE antibacterial composite sponge, the specific steps are as follows:
[0049] (1) Under stirring, a molecular weight of 25,000 shell glycans was dissolved in a vivo acetic acid solution having a percentage concentration of 0.8% to obtain a chitosan solution having a chitosan concentration of 5 g / L.
[0050] (2) Under stirring, N- (2-hydroxyethyl) acrylamide (N- (2-hydroxyethyl) acrylamide (N- (2-hydroxyethyl) acrylamide is 1: 1), and mixed in chitosan acetate solution. Uniform, given a mixed solution;
[0051] (3) Under stirring conditions, add Ti to a mixed solution. 3 C 2 T x , Mix evenly, get 20g / lti 3 C 2 T x Chitosan / N- (2-hydroxyethyl) acrylamide / Ti 3 C 2 T x The mixed solution; the mixed solution was freeze dried to give the hemostasis chitosan / MXENE antibacterial composite sponge.
[0052] Example 3 Preparation of chitosan / MXENE antibacterial composite sponge showed a microstructure of complex longitudinal interle...
PUM
| Property | Measurement | Unit |
|---|---|---|
| concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


